Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases

被引:0
作者
Chen, Wan [1 ,3 ]
Li, Mei-Ling [1 ]
Zeng, Guang [1 ]
Xu, Xiang-Yu [1 ]
Yin, Shan-Hui [1 ]
Xu, Can [1 ]
Li, Linlin [3 ]
Wen, Kaikai [3 ]
Yu, Xiao-Hua [2 ]
Wang, Gang [1 ]
机构
[1] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Cardiol, Hengyang 421001, Hunan, Peoples R China
[2] Hainan Med Univ, Inst Clin Med, Affiliated Hosp 2, Haikou 570100, Hainan, Peoples R China
[3] Chinese Acad Sci, Beijing Inst Nanoenergy & Nanosyst, Beijing 101400, Peoples R China
基金
中国国家自然科学基金;
关键词
Cardiovascular diseases; Metabolic diseases; Gut microbiota; Gut microbiota-derived metabolite; Phenylacetylglutamine; ORGANIC ANION TRANSPORTERS; FATTY LIVER-DISEASE; PHENYLACETALDEHYDE DEHYDROGENASE; PHENYLALANINE DEHYDROGENASE; UREMIC TOXIN; HEALTH; ACID; TRANSPLANTATION; OBESITY; INFLAMMATION;
D O I
10.1016/j.phrs.2025.107794
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aging of population coupled with unhealthy dietary habits among residents has led to a rise in the incidence of cardiovascular and metabolic diseases (CVMDs). Extensive research has highlighted the role of gut microbiotaderived metabolites in CVMDs. Among these metabolites, phenylacetylglutamine (PAGln), a meta-organismal prothrombotic metabolite, has been proved to promote the progression of CVMDs. This bacterial derived metabolite is a byproduct of amino acid comes from phenylalanine (Phe) in the diet. There are increasing evidence showing that the level of PAGln is associated with the risk of developing CVMDs. To provide a comprehensive understanding of the role of PAGln in CVMDs, this review delves into the production and metabolic pathways of PAGln and discusses the links of PAGln and the pathogenesis of CVMDs.
引用
收藏
页数:12
相关论文
共 141 条
[1]   Gut microbiota-derived metabolites as central regulators in metabolic disorders [J].
Agus, Allison ;
Clement, Karine ;
Sokol, Harry .
GUT, 2021, 70 (06) :1174-1182
[2]   Role of gut microbiota in intestinal wound healing and barrier function [J].
Alam, Ashfaqul ;
Neish, Andrew .
TISSUE BARRIERS, 2018, 6 (03)
[3]   Microbial metabolites are associated with a high adherence to a Mediterranean dietary pattern using a 1H-NMR-based untargeted metabolomics approach [J].
Almanza-Aguilera, Enrique ;
Urpi-Sarda, Mireia ;
Llorach, Rafael ;
Vazquez-Fresno, Rosa ;
Garcia-Aloy, Mar ;
Carmona, Francesc ;
Sanchez, Alex ;
Madrid-Gambin, Francisco ;
Estruch, Ramon ;
Corella, Dolores ;
Andres-Lacueva, Cristina .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2017, 48 :36-43
[4]   Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia [J].
Andrade, Fernando ;
Cano, Ainara ;
Suarez, Maria Unceta ;
Arza, Arantza ;
Vinuesa, Ana ;
Ceberio, Leticia ;
Lopez-Osle, Nuria ;
de Frutos, Gorka ;
Lopez-Oceja, Raquel ;
Aznal, Elena ;
Gonzalez-Lamuno, Domingo ;
de las Heras, Javier .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
[5]   Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders [J].
Andrade, Fernando ;
Vitoria, Isidro ;
Martin Hernandez, Elena ;
Pintos-Morell, Guillem ;
Correcher, Patricia ;
Puig-Pina, Rocio ;
Quijada-Fraile, Pilar ;
Pena-Quintana, Luis ;
Ma Marquez, Ana ;
Villate, Olatz ;
Garcia Silva, Ma Teresa ;
de las Heras, Javier ;
Ceberio, Leticia ;
Rodrigues, Esmeralda ;
Almeida Campos, Teresa ;
Yahyaoui, Raquel ;
Blasco, Javier ;
Vives-Pinera, Inmaculada ;
Gil, David ;
del Toro, Mireia ;
Ruiz-Pons, Monica ;
Canedo, Elvira ;
Barba Romero, Miguel Angel ;
Concepcion Garcia-Jimenez, Ma ;
Aldamiz-Echevarria, Luis .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 176
[6]   Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies [J].
Aron-Wisnewsky, Judith ;
Warmbrunn, Moritz V. ;
Nieuwdorp, Max ;
Clement, Karine .
GASTROENTEROLOGY, 2021, 160 (02) :573-599
[7]   PHENYLALANINE DEHYDROGENASE OF BACILLUS-BADIUS - PURIFICATION, CHARACTERIZATION AND GENE CLONING [J].
ASANO, Y ;
NAKAZAWA, A ;
ENDO, K ;
HIBINO, Y ;
OHMORI, M ;
NUMAO, N ;
KONDO, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 168 (01) :153-159
[8]   Gut-Microbiota-Metabolite Axis in Early Renal Function Decline [J].
Barrios, Clara ;
Beaumont, Michelle ;
Pallister, Tess ;
Villar, Judith ;
Goodrich, Julia K. ;
Clark, Andrew ;
Pascual, Julio ;
Ley, Ruth E. ;
Spector, Tim D. ;
Bell, Jordana T. ;
Menni, Cristina .
PLOS ONE, 2015, 10 (08)
[9]   Effect of Diet and Dietary Components on the Composition of the Gut Microbiota [J].
Beam, Ashley ;
Clinger, Elizabeth ;
Hao, Lei .
NUTRIENTS, 2021, 13 (08)
[10]   Niche-specific control of tissue function by regulatory T cells-Current challenges and for metabolic disease [J].
Becker, Maike ;
Dirschl, Sandra M. ;
Scherm, Martin G. ;
Serr, Isabelle ;
Daniel, Carolin .
CELL METABOLISM, 2024, 36 (02) :229-239